Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - griffithsin
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Anti-Viral Polypeptide
Griffithsin
: Compounds, Compositions, and Methods of Use
Abstract: This technology describes additional methods of using the
griffithsin
anti-viral polypeptides described in related NCI invention (reference number E-106-2003). Specifically, this invention describes the use of GRFT to inhibit viral infection of hepatitis C viral infection, a severe acute respiratory syndrome (SARS) viral infection, an H5N1...
Published: 4/8/2024
|
Inventor(s):
Barry O'Keefe
,
James McMahon
,
Toshiyuki Mori
Keywords(s):
Anti-Viral
,
Corona virus
,
Ebola
,
Griffithsin
,
INFLUENZA
,
O’Keefe
,
SARS
Category(s):
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Collaboration
,
Application > Therapeutics
,
Collaboration Sought > Licensing
Griffithsin
-Based Anti-viral Therapeutics with Improved Stability and Solubility
Abstract:
Griffithsin
is a potent anti-viral protein with activity against HIV, HCV, Sars, HSV 1 & 2 and other viruses. It is active against HIV and HCV at picomolar concentrations. Griffithsin is moving into clinical trials as an anti-HIV microbicide. Based on the structure of griffithsin and the necessities of pharmaceutical product development...
Published: 7/16/2024
|
Inventor(s):
Barry O'Keefe
,
Kenneth Palmer
,
Tinoush Moulaei
,
Lisa Rohan
,
Joshua Fuqua
,
Lindsay Kramzer
Keywords(s):
Anti-Viral
,
cnidarin
,
Griffithsin
,
HCV
,
HIV
,
HSV
,
SARS
Category(s):
Collaboration Sought > Licensing
,
Collaboration Sought > Collaboration
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
An Anti-Viral Polypeptide:
Griffithsin
Abstract: Virus entry into a susceptible host cell is the first step in the formation of all viral diseases. Controlling viral infections by disrupting viral entry is advantageous for antibody-mediated neutralization by the host’s immune system and as a preventive and therapeutic antiviral strategy. Plant-derived carbohydrate-binding proteins...
Published: 4/8/2024
|
Inventor(s):
Michael Boyd
,
Toshiyuki Mori
,
Barry O'Keefe
Keywords(s):
Griffithsin
,
O'Keefe
,
SARS
,
Severe acute respiratory syndrome
Category(s):
Collaboration Sought > Collaboration
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Licensing